
Global Psilocybin Assisted Therapy Market Analysis and Forecast 2025-2031
Description
Summary
According to APO Research, The global Psilocybin Assisted Therapy market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Psilocybin Assisted Therapy include ATAI Life Sciences, Compass Pathways, DemeRx, Eleusis, Field Trip, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals, MindMed and Verrian, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Psilocybin Assisted Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Psilocybin Assisted Therapy, also provides the sales of main regions and countries. Of the upcoming market potential for Psilocybin Assisted Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psilocybin Assisted Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Psilocybin Assisted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Psilocybin Assisted Therapy sales, projected growth trends, production technology, application and end-user industry.
Psilocybin Assisted Therapy Segment by Company
ATAI Life Sciences
Compass Pathways
DemeRx
Eleusis
Field Trip
Hikma Pharmaceuticals PLC
Jazz Pharmaceuticals
MindMed
Verrian
Pfizer
Psilocybin Assisted Therapy Segment by Type
Natural
Synthetic
Psilocybin Assisted Therapy Segment by Application
Psychiatric Disorders
Anxiety Disorders
Cluster Headaches
Psilocybin Assisted Therapy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psilocybin Assisted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Psilocybin Assisted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psilocybin Assisted Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Psilocybin Assisted Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psilocybin Assisted Therapy sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Psilocybin Assisted Therapy market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Psilocybin Assisted Therapy is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Psilocybin Assisted Therapy include ATAI Life Sciences, Compass Pathways, DemeRx, Eleusis, Field Trip, Hikma Pharmaceuticals PLC, Jazz Pharmaceuticals, MindMed and Verrian, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Psilocybin Assisted Therapy, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Psilocybin Assisted Therapy, also provides the sales of main regions and countries. Of the upcoming market potential for Psilocybin Assisted Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Psilocybin Assisted Therapy sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Psilocybin Assisted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Psilocybin Assisted Therapy sales, projected growth trends, production technology, application and end-user industry.
Psilocybin Assisted Therapy Segment by Company
ATAI Life Sciences
Compass Pathways
DemeRx
Eleusis
Field Trip
Hikma Pharmaceuticals PLC
Jazz Pharmaceuticals
MindMed
Verrian
Pfizer
Psilocybin Assisted Therapy Segment by Type
Natural
Synthetic
Psilocybin Assisted Therapy Segment by Application
Psychiatric Disorders
Anxiety Disorders
Cluster Headaches
Psilocybin Assisted Therapy Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Psilocybin Assisted Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Psilocybin Assisted Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Psilocybin Assisted Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Psilocybin Assisted Therapy in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Psilocybin Assisted Therapy manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Psilocybin Assisted Therapy sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Table of Contents
196 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Psilocybin Assisted Therapy Market by Type
- 1.2.1 Global Psilocybin Assisted Therapy Market Size by Type, 2020 VS 2024 VS 2031
- 1.2.2 Natural
- 1.2.3 Synthetic
- 1.3 Psilocybin Assisted Therapy Market by Application
- 1.3.1 Global Psilocybin Assisted Therapy Market Size by Application, 2020 VS 2024 VS 2031
- 1.3.2 Psychiatric Disorders
- 1.3.3 Anxiety Disorders
- 1.3.4 Cluster Headaches
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
- 2 Psilocybin Assisted Therapy Market Dynamics
- 2.1 Psilocybin Assisted Therapy Industry Trends
- 2.2 Psilocybin Assisted Therapy Industry Drivers
- 2.3 Psilocybin Assisted Therapy Industry Opportunities and Challenges
- 2.4 Psilocybin Assisted Therapy Industry Restraints
- 3 Global Market Growth Prospects
- 3.1 Global Psilocybin Assisted Therapy Revenue Estimates and Forecasts (2020-2031)
- 3.2 Global Psilocybin Assisted Therapy Revenue by Region
- 3.2.1 Global Psilocybin Assisted Therapy Revenue by Region: 2020 VS 2024 VS 2031
- 3.2.2 Global Psilocybin Assisted Therapy Revenue by Region (2020-2025)
- 3.2.3 Global Psilocybin Assisted Therapy Revenue by Region (2026-2031)
- 3.2.4 Global Psilocybin Assisted Therapy Revenue Market Share by Region (2020-2031)
- 3.3 Global Psilocybin Assisted Therapy Sales Estimates and Forecasts 2020-2031
- 3.4 Global Psilocybin Assisted Therapy Sales by Region
- 3.4.1 Global Psilocybin Assisted Therapy Sales by Region: 2020 VS 2024 VS 2031
- 3.4.2 Global Psilocybin Assisted Therapy Sales by Region (2020-2025)
- 3.4.3 Global Psilocybin Assisted Therapy Sales by Region (2026-2031)
- 3.4.4 Global Psilocybin Assisted Therapy Sales Market Share by Region (2020-2031)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
- 4 Market Competitive Landscape by Manufacturers
- 4.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers
- 4.1.1 Global Psilocybin Assisted Therapy Revenue by Manufacturers (2020-2025)
- 4.1.2 Global Psilocybin Assisted Therapy Revenue Market Share by Manufacturers (2020-2025)
- 4.1.3 Global Psilocybin Assisted Therapy Manufacturers Revenue Share Top 10 and Top 5 in 2024
- 4.2 Global Psilocybin Assisted Therapy Sales by Manufacturers
- 4.2.1 Global Psilocybin Assisted Therapy Sales by Manufacturers (2020-2025)
- 4.2.2 Global Psilocybin Assisted Therapy Sales Market Share by Manufacturers (2020-2025)
- 4.2.3 Global Psilocybin Assisted Therapy Manufacturers Sales Share Top 10 and Top 5 in 2024
- 4.3 Global Psilocybin Assisted Therapy Sales Price by Manufacturers (2020-2025)
- 4.4 Global Psilocybin Assisted Therapy Key Manufacturers Ranking, 2023 VS 2024 VS 2025
- 4.5 Global Psilocybin Assisted Therapy Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Psilocybin Assisted Therapy Manufacturers, Product Type & Application
- 4.7 Global Psilocybin Assisted Therapy Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Psilocybin Assisted Therapy Market CR5 and HHI
- 4.8.2 2024 Psilocybin Assisted Therapy Tier 1, Tier 2, and Tier 3
- 5 Psilocybin Assisted Therapy Market by Type
- 5.1 Global Psilocybin Assisted Therapy Revenue by Type
- 5.1.1 Global Psilocybin Assisted Therapy Revenue by Type (2020 VS 2024 VS 2031)
- 5.1.2 Global Psilocybin Assisted Therapy Revenue by Type (2020-2031) & (US$ Million)
- 5.1.3 Global Psilocybin Assisted Therapy Revenue Market Share by Type (2020-2031)
- 5.2 Global Psilocybin Assisted Therapy Sales by Type
- 5.2.1 Global Psilocybin Assisted Therapy Sales by Type (2020 VS 2024 VS 2031)
- 5.2.2 Global Psilocybin Assisted Therapy Sales by Type (2020-2031) & (K Units)
- 5.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Type (2020-2031)
- 5.3 Global Psilocybin Assisted Therapy Price by Type
- 6 Psilocybin Assisted Therapy Market by Application
- 6.1 Global Psilocybin Assisted Therapy Revenue by Application
- 6.1.1 Global Psilocybin Assisted Therapy Revenue by Application (2020 VS 2024 VS 2031)
- 6.1.2 Global Psilocybin Assisted Therapy Revenue by Application (2020-2031) & (US$ Million)
- 6.1.3 Global Psilocybin Assisted Therapy Revenue Market Share by Application (2020-2031)
- 6.2 Global Psilocybin Assisted Therapy Sales by Application
- 6.2.1 Global Psilocybin Assisted Therapy Sales by Application (2020 VS 2024 VS 2031)
- 6.2.2 Global Psilocybin Assisted Therapy Sales by Application (2020-2031) & (K Units)
- 6.2.3 Global Psilocybin Assisted Therapy Sales Market Share by Application (2020-2031)
- 6.3 Global Psilocybin Assisted Therapy Price by Application
- 7 Company Profiles
- 7.1 ATAI Life Sciences
- 7.1.1 ATAI Life Sciences Comapny Information
- 7.1.2 ATAI Life Sciences Business Overview
- 7.1.3 ATAI Life Sciences Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 ATAI Life Sciences Psilocybin Assisted Therapy Product Portfolio
- 7.1.5 ATAI Life Sciences Recent Developments
- 7.2 Compass Pathways
- 7.2.1 Compass Pathways Comapny Information
- 7.2.2 Compass Pathways Business Overview
- 7.2.3 Compass Pathways Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Compass Pathways Psilocybin Assisted Therapy Product Portfolio
- 7.2.5 Compass Pathways Recent Developments
- 7.3 DemeRx
- 7.3.1 DemeRx Comapny Information
- 7.3.2 DemeRx Business Overview
- 7.3.3 DemeRx Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 DemeRx Psilocybin Assisted Therapy Product Portfolio
- 7.3.5 DemeRx Recent Developments
- 7.4 Eleusis
- 7.4.1 Eleusis Comapny Information
- 7.4.2 Eleusis Business Overview
- 7.4.3 Eleusis Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Eleusis Psilocybin Assisted Therapy Product Portfolio
- 7.4.5 Eleusis Recent Developments
- 7.5 Field Trip
- 7.5.1 Field Trip Comapny Information
- 7.5.2 Field Trip Business Overview
- 7.5.3 Field Trip Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Field Trip Psilocybin Assisted Therapy Product Portfolio
- 7.5.5 Field Trip Recent Developments
- 7.6 Hikma Pharmaceuticals PLC
- 7.6.1 Hikma Pharmaceuticals PLC Comapny Information
- 7.6.2 Hikma Pharmaceuticals PLC Business Overview
- 7.6.3 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Hikma Pharmaceuticals PLC Psilocybin Assisted Therapy Product Portfolio
- 7.6.5 Hikma Pharmaceuticals PLC Recent Developments
- 7.7 Jazz Pharmaceuticals
- 7.7.1 Jazz Pharmaceuticals Comapny Information
- 7.7.2 Jazz Pharmaceuticals Business Overview
- 7.7.3 Jazz Pharmaceuticals Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.7.4 Jazz Pharmaceuticals Psilocybin Assisted Therapy Product Portfolio
- 7.7.5 Jazz Pharmaceuticals Recent Developments
- 7.8 MindMed
- 7.8.1 MindMed Comapny Information
- 7.8.2 MindMed Business Overview
- 7.8.3 MindMed Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.8.4 MindMed Psilocybin Assisted Therapy Product Portfolio
- 7.8.5 MindMed Recent Developments
- 7.9 Verrian
- 7.9.1 Verrian Comapny Information
- 7.9.2 Verrian Business Overview
- 7.9.3 Verrian Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.9.4 Verrian Psilocybin Assisted Therapy Product Portfolio
- 7.9.5 Verrian Recent Developments
- 7.10 Pfizer
- 7.10.1 Pfizer Comapny Information
- 7.10.2 Pfizer Business Overview
- 7.10.3 Pfizer Psilocybin Assisted Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.10.4 Pfizer Psilocybin Assisted Therapy Product Portfolio
- 7.10.5 Pfizer Recent Developments
- 8 North America
- 8.1 North America Psilocybin Assisted Therapy Market Size by Type
- 8.1.1 North America Psilocybin Assisted Therapy Revenue by Type (2020-2031)
- 8.1.2 North America Psilocybin Assisted Therapy Sales by Type (2020-2031)
- 8.1.3 North America Psilocybin Assisted Therapy Price by Type (2020-2031)
- 8.2 North America Psilocybin Assisted Therapy Market Size by Application
- 8.2.1 North America Psilocybin Assisted Therapy Revenue by Application (2020-2031)
- 8.2.2 North America Psilocybin Assisted Therapy Sales by Application (2020-2031)
- 8.2.3 North America Psilocybin Assisted Therapy Price by Application (2020-2031)
- 8.3 North America Psilocybin Assisted Therapy Market Size by Country
- 8.3.1 North America Psilocybin Assisted Therapy Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 8.3.2 North America Psilocybin Assisted Therapy Sales by Country (2020 VS 2024 VS 2031)
- 8.3.3 North America Psilocybin Assisted Therapy Price by Country (2020-2031)
- 8.3.4 United States
- 8.3.5 Canada
- 9 Europe
- 9.1 Europe Psilocybin Assisted Therapy Market Size by Type
- 9.1.1 Europe Psilocybin Assisted Therapy Revenue by Type (2020-2031)
- 9.1.2 Europe Psilocybin Assisted Therapy Sales by Type (2020-2031)
- 9.1.3 Europe Psilocybin Assisted Therapy Price by Type (2020-2031)
- 9.2 Europe Psilocybin Assisted Therapy Market Size by Application
- 9.2.1 Europe Psilocybin Assisted Therapy Revenue by Application (2020-2031)
- 9.2.2 Europe Psilocybin Assisted Therapy Sales by Application (2020-2031)
- 9.2.3 Europe Psilocybin Assisted Therapy Price by Application (2020-2031)
- 9.3 Europe Psilocybin Assisted Therapy Market Size by Country
- 9.3.1 Europe Psilocybin Assisted Therapy Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 9.3.2 Europe Psilocybin Assisted Therapy Sales by Country (2020 VS 2024 VS 2031)
- 9.3.3 Europe Psilocybin Assisted Therapy Price by Country (2020-2031)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
- 9.3.9 Nordic Countries
- 10 China
- 10.1 China Psilocybin Assisted Therapy Market Size by Type
- 10.1.1 China Psilocybin Assisted Therapy Revenue by Type (2020-2031)
- 10.1.2 China Psilocybin Assisted Therapy Sales by Type (2020-2031)
- 10.1.3 China Psilocybin Assisted Therapy Price by Type (2020-2031)
- 10.2 China Psilocybin Assisted Therapy Market Size by Application
- 10.2.1 China Psilocybin Assisted Therapy Revenue by Application (2020-2031)
- 10.2.2 China Psilocybin Assisted Therapy Sales by Application (2020-2031)
- 10.2.3 China Psilocybin Assisted Therapy Price by Application (2020-2031)
- 11 Asia (Excluding China)
- 11.1 Asia Psilocybin Assisted Therapy Market Size by Type
- 11.1.1 Asia Psilocybin Assisted Therapy Revenue by Type (2020-2031)
- 11.1.2 Asia Psilocybin Assisted Therapy Sales by Type (2020-2031)
- 11.1.3 Asia Psilocybin Assisted Therapy Price by Type (2020-2031)
- 11.2 Asia Psilocybin Assisted Therapy Market Size by Application
- 11.2.1 Asia Psilocybin Assisted Therapy Revenue by Application (2020-2031)
- 11.2.2 Asia Psilocybin Assisted Therapy Sales by Application (2020-2031)
- 11.2.3 Asia Psilocybin Assisted Therapy Price by Application (2020-2031)
- 11.3 Asia Psilocybin Assisted Therapy Market Size by Country
- 11.3.1 Asia Psilocybin Assisted Therapy Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 11.3.2 Asia Psilocybin Assisted Therapy Sales by Country (2020 VS 2024 VS 2031)
- 11.3.3 Asia Psilocybin Assisted Therapy Price by Country (2020-2031)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
- 12 South America, Middle East and Africa
- 12.1 SAMEA Psilocybin Assisted Therapy Market Size by Type
- 12.1.1 SAMEA Psilocybin Assisted Therapy Revenue by Type (2020-2031)
- 12.1.2 SAMEA Psilocybin Assisted Therapy Sales by Type (2020-2031)
- 12.1.3 SAMEA Psilocybin Assisted Therapy Price by Type (2020-2031)
- 12.2 SAMEA Psilocybin Assisted Therapy Market Size by Application
- 12.2.1 SAMEA Psilocybin Assisted Therapy Revenue by Application (2020-2031)
- 12.2.2 SAMEA Psilocybin Assisted Therapy Sales by Application (2020-2031)
- 12.2.3 SAMEA Psilocybin Assisted Therapy Price by Application (2020-2031)
- 12.3 SAMEA Psilocybin Assisted Therapy Market Size by Country
- 12.3.1 SAMEA Psilocybin Assisted Therapy Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
- 12.3.2 SAMEA Psilocybin Assisted Therapy Sales by Country (2020 VS 2024 VS 2031)
- 12.3.3 SAMEA Psilocybin Assisted Therapy Price by Country (2020-2031)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
- 13 Value Chain and Sales Channels Analysis
- 13.1 Psilocybin Assisted Therapy Value Chain Analysis
- 13.1.1 Psilocybin Assisted Therapy Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Psilocybin Assisted Therapy Production Mode & Process
- 13.2 Psilocybin Assisted Therapy Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Psilocybin Assisted Therapy Distributors
- 13.2.3 Psilocybin Assisted Therapy Customers
- 14 Concluding Insights
- 15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.